Brainstorm Cell Therapeutics (BCLI) News Today

$0.22

-0.08 (-26.49%)

(As of 12/7/2023 ET)

Today's Range: $0.22
▼
$0.27
50-Day Range: $0.15
▼
$0.40
52-Week Range: $0.13
▼
$3.46

Volume: 6.01 million shs
Average Volume: 1.09 million shs
Market Capitalization: $10.87 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.00

Source

Source	Headline
	Why BrainStorm Cell Therapeutics Shares Are Falling msn.com - December 7 at 7:08 PM
	BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS finance.yahoo.com - December 7 at 9:06 AM
	Brainstorm Cell Therapeutics (NASDAQ:BCLI) Now Covered by Analysts at StockNews.com americanbankingnews.com - December 6 at 1:28 AM
	Brainstorm Cell Therapeutics Inc BCLI morningstar.com - November 28 at 6:16 PM
	Brainstorm Cell Therapeutics (NASDAQ:BCLI) Research Coverage Started at StockNews.com americanbankingnews.com - November 28 at 1:10 AM
	INVESTOR ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BCLI barrons.com - November 26 at 12:06 AM
	SHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline -- BCLI barrons.com - November 23 at 11:55 PM
	Brainstorm Cell Therapeutics Inc. Class Action Reminder: Contact Robbins LLP for Information About the BCLI Class Action benzinga.com - November 21 at 9:10 PM
	Brainstorm Cell Therapeutics (NASDAQ:BCLI) to Meet with FDA for New Treatment Plans msn.com - November 21 at 8:50 AM
	BCLI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Brainstorm Cell Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! businesswire.com - November 20 at 3:06 PM
	SHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - BCLI barrons.com - November 20 at 12:12 PM
	BrainStorm Cell Therapeutics: FDA Grants In-person Meeting To Discuss Best Path Forward For NurOwn markets.businessinsider.com - November 20 at 12:12 PM
	BrainStorm Cell Therapeutics Announces In-Person Meeting with the FDA to Discuss Confirmatory Phase 3 Trial for NurOwn® in ALS finance.yahoo.com - November 20 at 12:12 PM
	BrainStorm Cell Therapeutics to Present at 6th Annual ALS Research Symposia finance.yahoo.com - November 17 at 7:10 AM
	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. (BCLI) benzinga.com - November 16 at 8:18 PM
	BCLI: Phase 3b Trial Details to be Discussed with FDA… finance.yahoo.com - November 16 at 3:11 PM
	Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 15 at 6:16 PM
	Q3 2023 Brainstorm Cell Therapeutics Inc Earnings Call finance.yahoo.com - November 15 at 8:11 AM
	BrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update finanznachrichten.de - November 14 at 9:27 AM
	BrainStorm Cell Therapeutics Announces Third quarter 2023 Financial Results and Provides Corporate Update finance.yahoo.com - November 14 at 9:27 AM
	Brainstorm Cell Therapeutics Inc. (BCLI) Investors: Shareholders with Large Losses Should Contact Robbins LLP Regarding the BCLI Class Action businesswire.com - November 14 at 12:21 AM
	SHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc.(BCLI) Investors of a Class Action Lawsuit and Upcoming Deadline benzinga.com - November 9 at 5:33 PM
	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Brainstorm Cell Therapeutics Inc. (BCLI) Investors businesswire.com - November 8 at 9:15 PM
	The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Brainstorm Cell Therapeutics Inc. (BCLI) Investors benzinga.com - November 7 at 12:46 PM
	BrainStorm to Announce Third Quarter 2023 Financial Results and Provide a Corporate Update finance.yahoo.com - November 7 at 7:35 AM
	INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of Investors tmcnet.com - November 6 at 3:57 PM
	SHAREHOLDER ALERT: Levi & Korsinsky Notifies Brainstorm Cell Therapeutics Inc. (BCLI) Investors of a Class Action Lawsuit and Upcoming Deadline benzinga.com - November 6 at 3:57 PM
	Brainstorm Cell Therapeutics Inc. (BCS) Investor Notice: Robbins LLP Reminds Investors of Class Action Against Brainstorm Cell Therapeutics Inc. stockhouse.com - November 6 at 3:57 PM
	The Law Offices of Frank R. Cruz Announces Investigation of Brainstorm Cell Therapeutics Inc. (BCLI) on Behalf of Investors businesswire.com - November 3 at 11:40 PM
	Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Brainstorm Cell Therapeutics Inc. (BCS) benzinga.com - November 3 at 6:40 PM
	Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. (BCLI) benzinga.com - November 2 at 7:53 PM
	EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Brainstorm Cell Therapeutics Inc. – BCLI businesswire.com - November 1 at 11:43 PM
	BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn® for the Treatment of ALS finance.yahoo.com - October 24 at 8:32 AM
	BCLI: Meeting with FDA to Discuss Development Plan for NurOwn®… finance.yahoo.com - October 23 at 3:36 PM
	BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS finance.yahoo.com - October 18 at 8:01 AM
	ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI stockhouse.com - October 9 at 9:38 AM
	ROSEN, A TOP RANKED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI benzinga.com - October 7 at 2:53 PM
	BCLI: Advisory Panel Votes Against Recommending Approval of NurOwn®… finance.yahoo.com - October 2 at 3:06 PM
	BrainStorm shares plunge 56% after FDA advisers reject ALS cell therapy proactiveinvestors.com - September 28 at 6:15 PM
	BrainStorm shares plunge 56% after FDA advisors reject ALS cell therapy proactiveinvestors.com - September 28 at 6:15 PM
	ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI tmcnet.com - September 28 at 6:15 PM
	FDA panel rejects ALS treatment from Brainstorm Cell Therapeutics msn.com - September 28 at 8:15 AM
	BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS finance.yahoo.com - September 28 at 12:46 AM
	FDA advisers vote against experimental ALS treatment pushed by patients finance.yahoo.com - September 27 at 7:46 PM
	BrainStorm Cell Therapeutics Inc.: BrainStorm Cell Therapeutics Stock Trading Halted Today finanznachrichten.de - September 27 at 9:44 AM
	BrainStorm Cell Therapeutics Stock Trading Halted Today finance.yahoo.com - September 27 at 9:44 AM
	marketbeat.com - September 27 at 6:58 AM
	BCLI: Public Support for NurOwn® from Prominent ALS Specialists… finance.yahoo.com - September 26 at 6:43 PM
	BrainStorm Cell plummets after FDA raises doubts over ALS therapy proactiveinvestors.com - September 25 at 2:19 PM
	Why Is Neurodegenerative Disease-Focused Brainstorm Cell Therapeutics Stock Plunging Today? msn.com - September 25 at 2:19 PM

Get Brainstorm Cell Therapeutics News Delivered to You Automatically

BCLI Media Mentions By Week

BCLI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCLI
News Sentiment
▼
0.00

0.51
▲
Average
Medical
News Sentiment

BCLI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCLI Articles
This Week
▼
3

1
▲
BCLI Articles
Average Week

Get Brainstorm Cell Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:BCLI) was last updated on 12/8/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Brainstorm Cell Therapeutics (BCLI) News Today

BCLI Media Mentions By Week

BCLI Media Sentiment

BCLI News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info